The 5 Best-Selling Drugs of 2017
We spent $328.6 billion on prescription drugs in 2016 -- and that's just the United States. The amount will no doubt be higher when the books are closed on 2017.
Payers and patients across the world are on track to spend $48 billion this year on just five drugs sold by AbbVie (NYSE: ABBV), Amgen (NASDAQ: AMGN), Celgene (NASDAQ: CELG), Roche (NASDAQOTH: RHHBY), and Pfizer (NYSE: PFE). Some of these drugs could make even more money in 2018, but others are likely to drop off the list. Here are the top five best-selling drugs in the world so far in 2017.
Image source: Getty Images.
Source: Fool.com
AbbVie Inc. Stock
€176.98
0.020%
The stock is an absolute favorite of our community with 33 Buy predictions and no Sell predictions.
As a result the target price of 181 € shows a slightly positive potential of 2.27% compared to the current price of 176.98 € for AbbVie Inc..
